Derli Conceição Munhoz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Derli Conceição Munhoz has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Elaine Cristina de Ataide
Universidade Estadual de Campinas
4 shared publications - Ilka de Fátima Santana Ferreira Boin
Universidade Estadual de Campinas (UNICAMP)
4 shared publications - Cristina Aparecida Arrivabene Caruy
Universidade Estadual de Campinas
3 shared publications - Adilson Roberto Cardoso
Universidade Estadual de Campinas
2 shared publications - Alexandre Foratto
Universidade Estadual de Campinas
2 shared publications - André Henrique Miyoshi
Universidade Estadual de Campinas
2 shared publications
Latest Publications
- Open Access
- 31 March 2026
- Published by Universidade Estadual de Campinas in Revista Saberes Universitários
- Vol. 5, e026009
Manejo de via aérea difícil em anestesia
Introduction: The difficult airway (DAV) is a significant challenge in anesthesiology and can lead to serious complications such as hypoxia and death. Effective management of DAV requires a multidisciplinary approach and the use of specialized equipment, as well as clear protocols. Aim: to describe the results of implementing a safety protocol for anesthetic procedures in patients with VAD in the Surgical Centre of a university hospital. Methods: Experience report. The Plan-Do-Check-Act (PDCA) cycle was used as a tool to implement the VAD management protocol. VAD indicators were analyzed between November 2023 and August 2024, the period after the team was trained and the protocol was implemented. Data was collected from administrative and operational records. Results: In total, 100 patients with VAD were identified in 6,283 surgeries (1.59%), the majority of whom were male (61%) with a mean age of 49.23 years. Around 68 per cent of patients were classified as ASA III and 86 per cent had Mallampati grades 3 and 4, reflecting greater difficulty in intubation. The specialities with the highest prevalence of VAD were neurosurgery (13%), head and neck surgery (12%) and urology (10%), with 79% of elective surgeries. The videolaryngoscope was the most commonly used device (50 per cent) and 10 per cent of cases had complications. Conclusions: The implementation of the protocol based on the PDCA cycle showed positive results, reinforcing the need for structured protocols and collaboration between health professionals. Future research should explore the long-term effectiveness of this approach.
- 31 March 2026
- Published by Universidade Estadual de Campinas in Revista Saberes Universitários
- Vol. 5, e026009
Open AccessManejo de via aérea difícil em anestesia
Introduction: The difficult airway (DAV) is a significant challenge in anesthesiology and can lead to serious complications such as hypoxia and death. Effective management of DAV requires a multidisciplinary approach and the use of specialized equipment, as well as clear protocols. Aim: to describe the results of implementing a safety protocol for anesthetic procedures in patients with VAD in the Surgical Centre of a university hospital. Methods: Experience report. The Plan-Do-Check-Act (PDCA) cycle was used as a tool to implement the VAD management protocol. VAD indicators were analyzed between November 2023 and August 2024, the period after the team was trained and the protocol was implemented. Data was collected from administrative and operational records. Results: In total, 100 patients with VAD were identified in 6,283 surgeries (1.59%), the majority of whom were male (61%) with a mean age of 49.23 years. Around 68 per cent of patients were classified as ASA III and 86 per cent had Mallampati grades 3 and 4, reflecting greater difficulty in intubation. The specialities with the highest prevalence of VAD were neurosurgery (13%), head and neck surgery (12%) and urology (10%), with 79% of elective surgeries. The videolaryngoscope was the most commonly used device (50 per cent) and 10 per cent of cases had complications. Conclusions: The implementation of the protocol based on the PDCA cycle showed positive results, reinforcing the need for structured protocols and collaboration between health professionals. Future research should explore the long-term effectiveness of this approach.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 59, e15116
Influence of sex and gonadal hormones on pain perception in a neuropathic pain model in old rats
Despite growing evidence that nociceptive stimuli are processed and modulated by distinct neural mechanisms depending on biological sex and aging, these factors remain underrepresented in experimental and clinical pain research. Most preclinical studies continue to rely on young male rodents, overlooking potential differences in neuropathic pain perception between sexes and age groups. Understanding these variations is critical for advancing pain management strategies. Aged rats (22 months old) of both sexes were divided into three groups: orchiectomized (Orch) males, non-orchiectomized (Non-orch) males, and females. The animals underwent L5 spinal nerve ligation and were assessed for mechanical allodynia on the plantar surface of their left hind paw before nerve ligation and on days 7, 14, 21, and 28 post-ligation. By day 14, Non-orch males showed a significantly higher withdrawal threshold than Orch males, with an average difference of 8.46 g (P<0.005), which remained significant and increased over time, peaking at day 28, with 13.07 g (P<0.0006). By day 28, Non-orch males also showed greater mechanical allodynia than females, with an estimated mean difference of approximately 8 g (P=0.038). These findings suggest that male gonadal hormones mitigate neuropathic pain-induced mechanical allodynia. The study underscores the role of testosterone in pain modulation and highlights the need for further research on the interplay between hormonal regulation, aging, and neuropathic pain mechanisms.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 59, e15116
Open AccessInfluence of sex and gonadal hormones on pain perception in a neuropathic pain model in old rats
Despite growing evidence that nociceptive stimuli are processed and modulated by distinct neural mechanisms depending on biological sex and aging, these factors remain underrepresented in experimental and clinical pain research. Most preclinical studies continue to rely on young male rodents, overlooking potential differences in neuropathic pain perception between sexes and age groups. Understanding these variations is critical for advancing pain management strategies. Aged rats (22 months old) of both sexes were divided into three groups: orchiectomized (Orch) males, non-orchiectomized (Non-orch) males, and females. The animals underwent L5 spinal nerve ligation and were assessed for mechanical allodynia on the plantar surface of their left hind paw before nerve ligation and on days 7, 14, 21, and 28 post-ligation. By day 14, Non-orch males showed a significantly higher withdrawal threshold than Orch males, with an average difference of 8.46 g (P<0.005), which remained significant and increased over time, peaking at day 28, with 13.07 g (P<0.0006). By day 28, Non-orch males also showed greater mechanical allodynia than females, with an estimated mean difference of approximately 8 g (P=0.038). These findings suggest that male gonadal hormones mitigate neuropathic pain-induced mechanical allodynia. The study underscores the role of testosterone in pain modulation and highlights the need for further research on the interplay between hormonal regulation, aging, and neuropathic pain mechanisms.
- Open Access
- 3 February 2025
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 28 (1)
Sobrevivência a Longo Prazo após Transplante Ortotópico de Fígado: Análise de 20 anos em um Centro de Transplante em Campinas, Brasil
Introdução: O transplante ortotópico de fígado (TOF) é a principal terapia para doença hepática terminal. No Brasil, a realização de transplantes aumentou significativamente nas últimas décadas, com melhorias nos desfechos a longo prazo. Este estudo analisa a sobrevida de pacientes submetidos a TOF ao longo de 20 anos em um centro de referência. Métodos: Foram revisados os prontuários de 848 pacientes transplantados entre fevereiro de 1995 e dezembro de 2017. Aplicaram-se critérios de exclusão, incluindo pacientes com sobrevida inferior a 6 meses, visando minimizar o impacto de complicações precoces no desfecho de longo prazo. Dessa forma, 174 pacientes foram incluídos. As variáveis analisadas envolveram dados do receptor, doador, enxerto, procedimento cirúrgico e evolução pós-operatória. A sobrevida foi avaliada por Kaplan–Meier. Resultados: Dos 174 pacientes analisados, 98 (56,3%) mantiveram seguimento ambulatorial e 76 (43,7%) evoluíram a óbito. A média de idade no transplante foi de 47 anos, e 75% dos receptores eram do sexo masculino. As principais indicações foram hepatite viral (59,8%) e carcinoma hepatocelular (11,6%). A média do escore MELD foi 18. A principal causa de morte foi evento cardiovascular (36,4%), seguido de recidiva da doença hepática (22,1%) e neoplasias (15,6%). O tempo médio de sobrevida foi de 223 meses entre os pacientes vivos e 112 meses entre os óbitos (p < 0,0001). Maior tempo de isquemia fria, insuficiência renal pós-operatória, diabetes e maior tempo de internação em UTI foram fatores associados a pior sobrevida. Pacientes mais jovens apresentaram sobrevida significativamente superior (p = 0,00007). Conclusão: A análise de 20 anos mostrou que o TOF apresenta boa sobrevida a longo prazo, mas fatores como diabetes, disfunção renal e tempo prolongado de isquemia fria impactam negativamente os desfechos. Eventos cardiovasculares e recidiva da doença hepática foram as principais causas de mortalidade.
- 3 February 2025
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 28 (1)
Open AccessSobrevivência a Longo Prazo após Transplante Ortotópico de Fígado: Análise de 20 anos em um Centro de Transplante em Campinas, Brasil
Introdução: O transplante ortotópico de fígado (TOF) é a principal terapia para doença hepática terminal. No Brasil, a realização de transplantes aumentou significativamente nas últimas décadas, com melhorias nos desfechos a longo prazo. Este estudo analisa a sobrevida de pacientes submetidos a TOF ao longo de 20 anos em um centro de referência. Métodos: Foram revisados os prontuários de 848 pacientes transplantados entre fevereiro de 1995 e dezembro de 2017. Aplicaram-se critérios de exclusão, incluindo pacientes com sobrevida inferior a 6 meses, visando minimizar o impacto de complicações precoces no desfecho de longo prazo. Dessa forma, 174 pacientes foram incluídos. As variáveis analisadas envolveram dados do receptor, doador, enxerto, procedimento cirúrgico e evolução pós-operatória. A sobrevida foi avaliada por Kaplan–Meier. Resultados: Dos 174 pacientes analisados, 98 (56,3%) mantiveram seguimento ambulatorial e 76 (43,7%) evoluíram a óbito. A média de idade no transplante foi de 47 anos, e 75% dos receptores eram do sexo masculino. As principais indicações foram hepatite viral (59,8%) e carcinoma hepatocelular (11,6%). A média do escore MELD foi 18. A principal causa de morte foi evento cardiovascular (36,4%), seguido de recidiva da doença hepática (22,1%) e neoplasias (15,6%). O tempo médio de sobrevida foi de 223 meses entre os pacientes vivos e 112 meses entre os óbitos (p < 0,0001). Maior tempo de isquemia fria, insuficiência renal pós-operatória, diabetes e maior tempo de internação em UTI foram fatores associados a pior sobrevida. Pacientes mais jovens apresentaram sobrevida significativamente superior (p = 0,00007). Conclusão: A análise de 20 anos mostrou que o TOF apresenta boa sobrevida a longo prazo, mas fatores como diabetes, disfunção renal e tempo prolongado de isquemia fria impactam negativamente os desfechos. Eventos cardiovasculares e recidiva da doença hepática foram as principais causas de mortalidade.
- Open Access
- 3 February 2025
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 28 (1)
Long-Term Survival after Orthotopic Liver Transplant: 20-year analysis at a Transplant Center in Campinas, Brazil
Introduction: Orthotopic liver transplantation (OLT) is the primary therapy for end-stage liver disease. In Brazil, the number of liver transplants has significantly increased over the past decades, improving long-term outcomes. This study analyzes the long-term survival of patients who underwent OLT over 20 years at a reference transplant center. Methods: Medical records of 848 patients who underwent OLT between February 1995 and December 2017 were reviewed. Exclusion criteria included patients with survival below six months to minimize the impact of early postoperative complications on long-term outcomes. Thus, 174 patients were included. The analyzed variables involved the recipient, donor, graft, surgical procedure, and postoperative evolution. Survival was assessed using Kaplan–Meier analysis. Results: Among the 174 analyzed patients, 98 (56.3%) remained in outpatient follow-up, while 76 (43.7%) died. The mean age at transplantation was 47 years, and 75% of recipients were male. The main indications were viral hepatitis (59.8%) and hepatocellular carcinoma (11.6%). The mean MELD score was 18. The leading cause of death was cardiovascular events (36.4%), followed by liver disease recurrence (22.1%) and malignancies (15.6%). The mean survival time was 223 months for surviving patients and 112 months for deceased patients (p < 0.0001). Longer cold ischemia time, postoperative renal dysfunction, diabetes, and prolonged stay in the intensive care unit were associated with worse survival. Younger patients had significantly longer survival (p = 0.00007). Conclusion: The 20-year analysis demonstrated that OLT provides good long-term survival; however, factors such as diabetes, renal dysfunction, and prolonged cold ischemia time negatively impact the outcomes. Cardiovascular events and recurrence of liver disease were the leading causes of mortality.
- 3 February 2025
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 28 (1)
Open AccessLong-Term Survival after Orthotopic Liver Transplant: 20-year analysis at a Transplant Center in Campinas, Brazil
Introduction: Orthotopic liver transplantation (OLT) is the primary therapy for end-stage liver disease. In Brazil, the number of liver transplants has significantly increased over the past decades, improving long-term outcomes. This study analyzes the long-term survival of patients who underwent OLT over 20 years at a reference transplant center. Methods: Medical records of 848 patients who underwent OLT between February 1995 and December 2017 were reviewed. Exclusion criteria included patients with survival below six months to minimize the impact of early postoperative complications on long-term outcomes. Thus, 174 patients were included. The analyzed variables involved the recipient, donor, graft, surgical procedure, and postoperative evolution. Survival was assessed using Kaplan–Meier analysis. Results: Among the 174 analyzed patients, 98 (56.3%) remained in outpatient follow-up, while 76 (43.7%) died. The mean age at transplantation was 47 years, and 75% of recipients were male. The main indications were viral hepatitis (59.8%) and hepatocellular carcinoma (11.6%). The mean MELD score was 18. The leading cause of death was cardiovascular events (36.4%), followed by liver disease recurrence (22.1%) and malignancies (15.6%). The mean survival time was 223 months for surviving patients and 112 months for deceased patients (p < 0.0001). Longer cold ischemia time, postoperative renal dysfunction, diabetes, and prolonged stay in the intensive care unit were associated with worse survival. Younger patients had significantly longer survival (p = 0.00007). Conclusion: The 20-year analysis demonstrated that OLT provides good long-term survival; however, factors such as diabetes, renal dysfunction, and prolonged cold ischemia time negatively impact the outcomes. Cardiovascular events and recurrence of liver disease were the leading causes of mortality.
- Open Access
- 12 May 2024
- Published by Elsevier in Brazilian Journal of Anesthesiology (English Edition)
- Vol. 74 (4) , 844513
Cannabinoid products for pain management: recommendations from the São Paulo State Society of Anesthesiology
- 12 May 2024
- Published by Elsevier in Brazilian Journal of Anesthesiology (English Edition)
- Vol. 74 (4) , 844513
Open AccessCannabinoid products for pain management: recommendations from the São Paulo State Society of Anesthesiology
- Open Access
- 25 January 2023
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 26 (1)
Análise Perioperatória dos Pacientes Submetidos a Transplante Hepático no Hospital de Clínicas da Unicamp no Contexto da Pandemia de SARS-Cov-2
Introdução: A pandemia causada pelo SARS-CoV-2 teve início no ano de 2020 e ocasionou mudanças importantes no número de transplantes realizados nos hospitais e nos protocolos de admissão de candidatos para realização do procedimento. A Associação Brasileira de Transplante de Órgãos (ABTO) recomendava não realizar transplante de doadores com infecção COVID-19 ativa, teste positivo ou com Síndrome Respiratória Aguda Grave. As repercussões hepáticas relacionadas a COVID-19 são apresentadas em alguns relatos presentes na literatura médica. Estão bem documentadas as alterações hepáticas decorrentes de outros coronavírus tais como SARSCoV e MERS-CoV. O Hospital de Clínicas da Universidade Estadual de Campinas é um centro terciário que realiza transplantes de órgãos sólidos. Objetivos: Realizar a análise retrospectiva descritiva perioperatória dos transplantes hepáticos no contexto da pandemia por SARS-CoV-2 realizados no hospital das clínicas da Universidade Estadual de Campinas no período de março de 2020 a julho de 2021. Materiais e Métodos: Estudo retrospectivo, descritivo de coorte longitudinal baseado na revisão dos prontuários dos pacientes submetidos ao transplante hepático no contexto da pandemia por SARS-CoV-2 no período de março de 2020 a julho de 2021 no hospital de clínicas da Universidade Estadual de Campinas. Resultados: A análise retrospectiva foi realizada em 57 pacientes no período. Apenas 1 paciente precisou ser excluído por ter menos de 18 anos. Dos 56 pacientes, 52 realizaram coleta do exame laboratorial RT-PCR e tomografia (TC) de tórax. Desses 52 pacientes apenas 2 positivaram o exame, um pré transplante (TX) e um no pós-operatório (pós-op). Em relação às TC de tórax nenhuma apresentava alterações típicas para COVID pré-TX, no pós-op 4 pacientes apresentaram TC típicas. A média de idade foi de 55,86 anos. A taxa de mortalidade foi de 38% e nenhum óbito foi atribuído ao COVID 19. A escala de MELDNa média foi de 20,94. Conclusão: O presente estudo realizado no Hospital de Clínicas da Unicamp analisou a associação clínica, laboratorial e radiológica para melhor elucidar as variáveis determinadas pela COVID-19 no seu diagnóstico e manejo intra-hospitalar. Conclui-se que a pandemia por SARS-CoV-2 teve impacto na rotina de realização do transplante hepático mundialmente e no serviço no qual o estudo foi realizado.
- 25 January 2023
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 26 (1)
Open AccessAnálise Perioperatória dos Pacientes Submetidos a Transplante Hepático no Hospital de Clínicas da Unicamp no Contexto da Pandemia de SARS-Cov-2
Introdução: A pandemia causada pelo SARS-CoV-2 teve início no ano de 2020 e ocasionou mudanças importantes no número de transplantes realizados nos hospitais e nos protocolos de admissão de candidatos para realização do procedimento. A Associação Brasileira de Transplante de Órgãos (ABTO) recomendava não realizar transplante de doadores com infecção COVID-19 ativa, teste positivo ou com Síndrome Respiratória Aguda Grave. As repercussões hepáticas relacionadas a COVID-19 são apresentadas em alguns relatos presentes na literatura médica. Estão bem documentadas as alterações hepáticas decorrentes de outros coronavírus tais como SARSCoV e MERS-CoV. O Hospital de Clínicas da Universidade Estadual de Campinas é um centro terciário que realiza transplantes de órgãos sólidos. Objetivos: Realizar a análise retrospectiva descritiva perioperatória dos transplantes hepáticos no contexto da pandemia por SARS-CoV-2 realizados no hospital das clínicas da Universidade Estadual de Campinas no período de março de 2020 a julho de 2021. Materiais e Métodos: Estudo retrospectivo, descritivo de coorte longitudinal baseado na revisão dos prontuários dos pacientes submetidos ao transplante hepático no contexto da pandemia por SARS-CoV-2 no período de março de 2020 a julho de 2021 no hospital de clínicas da Universidade Estadual de Campinas. Resultados: A análise retrospectiva foi realizada em 57 pacientes no período. Apenas 1 paciente precisou ser excluído por ter menos de 18 anos. Dos 56 pacientes, 52 realizaram coleta do exame laboratorial RT-PCR e tomografia (TC) de tórax. Desses 52 pacientes apenas 2 positivaram o exame, um pré transplante (TX) e um no pós-operatório (pós-op). Em relação às TC de tórax nenhuma apresentava alterações típicas para COVID pré-TX, no pós-op 4 pacientes apresentaram TC típicas. A média de idade foi de 55,86 anos. A taxa de mortalidade foi de 38% e nenhum óbito foi atribuído ao COVID 19. A escala de MELDNa média foi de 20,94. Conclusão: O presente estudo realizado no Hospital de Clínicas da Unicamp analisou a associação clínica, laboratorial e radiológica para melhor elucidar as variáveis determinadas pela COVID-19 no seu diagnóstico e manejo intra-hospitalar. Conclui-se que a pandemia por SARS-CoV-2 teve impacto na rotina de realização do transplante hepático mundialmente e no serviço no qual o estudo foi realizado.
- Open Access
- 25 January 2023
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 26 (1)
Perioperative Analysis of Patients Undergoing Liver Transplantation at the Hospital de Clínicas da Unicamp in the Context of SARS-Cov-2 Pandemic
Introduction: SARS-CoV-2 began in 2020 and caused important changes in the number of transplants performed in hospitals and in the protocols for admitting candidates to perform the procedure. The Brazilian Association of Organ Transplantation (ABTO) recommends not performing transplants from donors with active COVID-19 infection, positive test results or with Severe Acute Respiratory Syndrome. The hepatic repercussions related to COVID-19 are presented in some reports in the medical literature. Liver changes resulting from other corona viruses such as SARS-CoV and MERS-CoV are well documented. The Hospital de Clínicas of the State University of Campinas is a tertiary center that performs solid organ transplants. Objectives: To carry out a perioperative, retrospective, descriptive analysis of liver transplants in the context of the SARS-CoV-2 pandemic carried out at the Hospital das Clínicas of the State University of Campinas from March 2020 to July 2021. Materials and Methods: Retrospective, descriptive, longitudinal cohort study based on the review of medical records of patients undergoing liver transplantation in the context of the SARS-CoV-2 pandemic from March 2020 to July 2021 at the clinical hospital of the State University of Campinas. Results:Retrospective analysis was performed on 57 patients in the period. Only 1 patient needed to be excluded because he was under 18 years old. Of the 56 patients, 52 underwent RT-PCR laboratory testing and chest tomography (CT). Of these 52 patients, only 2 tested positive, one pre-transplant (TX) and one post-operatively (post-op). Regarding chest CT scans, none of them showed typical changes for COVID pre-TX, in the post-op 4 patients presented typical chest CT scans. The average age was 55.86 years. The mortality rate was 38% and no deaths were attributed to COVID 19. The average MELD-Na scale was 20.94. Conclusion: The present study carried out at the Hospital de Clínicas da Unicamp analyzed the clinical, laboratory and radiological association to better elucidate the variables determined by COVID-19 in its diagnosis and in-hospital management. It is concluded that the SARS-CoV-2 pandemic had an impact on the routine of liver transplantation worldwide and on the service in which the study was carried out.
- 25 January 2023
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 26 (1)
Open AccessPerioperative Analysis of Patients Undergoing Liver Transplantation at the Hospital de Clínicas da Unicamp in the Context of SARS-Cov-2 Pandemic
Introduction: SARS-CoV-2 began in 2020 and caused important changes in the number of transplants performed in hospitals and in the protocols for admitting candidates to perform the procedure. The Brazilian Association of Organ Transplantation (ABTO) recommends not performing transplants from donors with active COVID-19 infection, positive test results or with Severe Acute Respiratory Syndrome. The hepatic repercussions related to COVID-19 are presented in some reports in the medical literature. Liver changes resulting from other corona viruses such as SARS-CoV and MERS-CoV are well documented. The Hospital de Clínicas of the State University of Campinas is a tertiary center that performs solid organ transplants. Objectives: To carry out a perioperative, retrospective, descriptive analysis of liver transplants in the context of the SARS-CoV-2 pandemic carried out at the Hospital das Clínicas of the State University of Campinas from March 2020 to July 2021. Materials and Methods: Retrospective, descriptive, longitudinal cohort study based on the review of medical records of patients undergoing liver transplantation in the context of the SARS-CoV-2 pandemic from March 2020 to July 2021 at the clinical hospital of the State University of Campinas. Results:Retrospective analysis was performed on 57 patients in the period. Only 1 patient needed to be excluded because he was under 18 years old. Of the 56 patients, 52 underwent RT-PCR laboratory testing and chest tomography (CT). Of these 52 patients, only 2 tested positive, one pre-transplant (TX) and one post-operatively (post-op). Regarding chest CT scans, none of them showed typical changes for COVID pre-TX, in the post-op 4 patients presented typical chest CT scans. The average age was 55.86 years. The mortality rate was 38% and no deaths were attributed to COVID 19. The average MELD-Na scale was 20.94. Conclusion: The present study carried out at the Hospital de Clínicas da Unicamp analyzed the clinical, laboratory and radiological association to better elucidate the variables determined by COVID-19 in its diagnosis and in-hospital management. It is concluded that the SARS-CoV-2 pandemic had an impact on the routine of liver transplantation worldwide and on the service in which the study was carried out.